Idiopathic thrombocytopenic purpura and the drug abciximab both target platelet membrane glycoprotein IIb-IIIa. ITP is an immune destruction of platelets. Besides being impossible to pronounce, abciximab is used in patients undergoing percutaneous coronary intervention, and is an antiplatelet agent.
You Can Get the Full Office 2024 Suite With Structured Lessons for Just
$106 Right Now
-
The courses help you move beyond basics and build practical skills at your
own pace.
20 minutes ago
Posts
quick question, doesnt idiopathic mean we dont know whats causing the dz? How can this be idiopathic, if we know its due to immune destruction?
ReplyDelete